Viewing Study NCT05464433


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-09 @ 11:35 AM
Study NCT ID: NCT05464433
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-13
First Post: 2022-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module